How to buy Genus shares | 3518p

Own Genus shares in just a few minutes.

Fact checked

Genus plc (GNS) is a leading biotechnology business based in the UK. It opened the day at 3592p after a previous close of 3522p. During the day the price has varied from a low of 3482p to a high of 3592p. The latest price was 3518p (25 minute delay). Genus is listed on the London Stock Exchange (LSE) and employs 3,000 staff. All prices are listed in pence sterling.

How to buy shares in Genus

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: GNS in this case.
  5. Research Genus shares. The platform should provide the latest information available.
  6. Buy your Genus shares. It's that simple.

How has Coronavirus impacted Genus's share price?

Since the stock market crash in March caused by coronavirus, Genus's share price has had significant positive movement.

Its last market close was 3532p, which is 6.74% up on its pre-crash value of 3294p and 43.31% up on the lowest point reached during the March crash when the shares fell as low as 2464.6p.

If you had bought £1,000 worth of Genus shares at the start of February 2020, those shares would have been worth £927.34 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth £1,146.84.

Genus share price

Use our graph to track the performance of GNS stocks over time.

Genus shares at a glance

Information last updated 2020-07-02.
Open3592p
High3592p
Low3482p
Close3518p
Previous close3522p
Change -4p
Change % -0.114%
Volume 61,567
Information last updated 2020-07-12.
52-week range2460p - 3760p
50-day moving average 3411.1177p
200-day moving average 3277.9858p
Wall St. target price2332.5p
PE ratio 58.9649
Dividend yield 0.28p (0.82%)
Earnings per share (TTM) 57.6p
Fineco

Get your first 50 trades commission free with Fineco

Fees apply. Your capital is at risk.

  • Market leading platform
  • No minimum deposit, no conversion fee, no monthly fee
  • Your first 50 share trades are free until 30/09/2020
Promoted

Share dealing platform comparison

Table: sorted by promoted deals first
Data indicated here is updated regularly
Name Product Price per trade Frequent trader rate Platform fees Brand description
Fineco
£2.95
£2.95
Zero platform fee
Fineco Bank is good for share traders and investors looking for a complete platform and wide offer. Your first 50 trades are free with Fineco, until 30/09/2020. T&Cs apply. Capital at risk.
IG
0% commission on US shares, and £3 on UK shares
From £5
£0 - £24 per quarter
IG is good for experienced traders, and offers learning resources for beginners, all with wide access to shares, ETFs and funds. Capital at risk.
Hargreaves Lansdown Fund & Share Account
£11.95
£5.95
Transfer out fee
Hargreaves Lansdown is the UK's biggest wealth manager, with the depth of features you'd expect from an established platform. Capital at risk.
eToro Free Stocks
0% commission, no markup, no ticket fee, no management fee
N/A
Withdrawal fee & GDP to USD deposit conversion
eToro is good for social trading - letting you mirror the portfolios of other traders. Capital at risk. 0% commission but other fees may apply.
Interactive Investor
From £7.99 on the Investor Service Plan
From £7.99 on the Investor Service Plan
No transfer fees or exit fees. £9.99 a month on the Investor Service Plan
Capital at risk.
loading

Compare up to 4 providers

Data indicated here is updated regularly
Name Product Minimum deposit Maximum annual fee Price per trade Brand description
Hargreaves Lansdown stocks and shares ISA
£100
0.45%
£11.95
Hargreaves Lansdown is the UK's biggest wealth manager. It's got everything you'll need, from beginners to experienced investors. Capital at risk.
Interactive Investor stocks and shares ISA
£100 or £25 a month
£119.88
£7.99
Interactive Investor offers everything most investors need. Its flat fees makes it pricey for small portfolios, but cheap for big ones. Capital at risk.
Saxo Markets stocks and shares ISA
No minimum deposit requirement
0.12%
£8.00
Saxo Markets offers a wide access to a range of stocks, ETFs and funds. Capital at risk.
AJ Bell stocks and shares ISA
£500
0.25%
£9.95
AJ Bell is a good all-rounder for people who to choose between shares, funds, ISAs and pensions. Capital at risk.
Fidelity stocks and shares ISA
£1000 or a regular savings plan from £50
0.35%
£10.00
Fidelity is another good all-rounder, offering a good package at a decent price. Not suited for trading shares. Capital at risk.
Nutmeg stocks and shares ISA
£100
0.75%
£0
Nutmeg offers three types of portfolios. Choose the one that goes with your investment style. Capital at risk.
loading

Compare up to 4 providers

Data indicated here is updated regularly
Name Product Minimum investment Choose from Annual fee Brand description
PensionBee Pension
No minimum
7 funds
0.5% - 0.95%
Pension Bee is a newbie in the pension market. It helps consolidate your pension plans into one place. Capital at risk.
Hargreaves Lansdown Pension
£100
2,500 funds
0-0.45%
Hargreaves Lansdown is the UK's biggest wealth manager. It's got three different retirement options. Capital at risk.
Interactive Investor Pension
£25/month
Over 2,500 funds
£10/month
interactive investor is a flat-fee platform, which makes it cost effective for larger portfolios. Capital at risk.
Saxo Markets Pension
Saxo Markets Pension
£10
Over 11,000 funds
No annual fee
Saxo Markets gives flexibility and control over your investment strategy. Capital at risk.
AJ Bell Pension
£1,000
Over 2,000 funds
0.05-0.25%
AJ Bell has two different pension options, a self managed pension and one that is managed for you. Capital at risk.
Moneybox Pension
£1
3 funds
0.15% - 0.45% charged monthly
Manage your money with an easy-to-use Moneybox app. Capital at risk.
Moneyfarm Pension
Moneyfarm Pension
0.35%-0.75%
7 funds
£1,500 (initial investment)
Moneyfarm has pensions that are matched against your risk appetite, goals and planned retirement date. Capital at risk.
loading

Compare up to 4 providers

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Capital is at risk.

Is it a good time to buy Genus stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Genus price performance over time

Historical closes compared with the last close of 3518p

1 week (2020-07-06) 0.23%
1 month (2020-06-12) 8.38%
3 months (2020-04-09) 5.20%
6 months (2020-01-13) 13.34%
1 year (2019-07-12) 34.58%
2 years (2018-07-13) 24.49%
3 years (2017-07-13) 103.47%
5 years (2015-07-13) 139.32%

Is Genus under- or over-valued?

Valuing Genus stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Genus's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Genus's P/E ratio

Genus's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 59x. In other words, Genus shares trade at around 59x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the FTSE 250 at the end of September 2019 (19.71). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Genus's EBITDA

Genus's EBITDA (earnings before interest, taxes, depreciation and amortisation) is £39.4 million.

The EBITDA is a measure of a Genus's overall financial performance and is widely used to measure a its profitability.

Genus financials

Revenue TTM £520.4 million
Operating margin TTM 3.34%
Gross profit TTM £186 million
Return on assets TTM 1.33%
Return on equity TTM 7.71%
Profit margin 7.44%
Book value 7.646p
Market capitalisation £2.2 billion

TTM: trailing 12 months

Genus share dividends

46%

Dividend payout ratio: 46.24% of net profits

Recently Genus has paid out, on average, around 46.24% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.82% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Genus shareholders could enjoy a 0.82% return on their shares, in the form of dividend payments. In Genus's case, that would currently equate to about 0.28p per share.

While Genus's payout ratio might seem fairly standard, it's worth remembering that Genus may be investing much of the rest of its net profits in future growth.

The latest dividend was paid out to all shareholders who bought their shares by 5 March 2020 (the "ex-dividend date").

Genus share price volatility

Over the last 12 months, Genus's shares have ranged in value from as little as 2460p up to 3760p. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while Genus's is 0.3901. This would suggest that Genus's shares are less volatile than average (for this exchange).

Genus overview

Genus plc operates as an animal genetics company in North America, Latin America, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates in three segments: Genus PIC, Genus ABS, and Research and Development. It sells sows, boars, and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands. In addition, it offers semen sexing, in vitro fertilization, reproductive, and other technical services to farmers. The company has a strategic porcine collaboration with Beijing Capital Agribusiness Co. Ltd to research, develop, register, and market porcine reproductive and respiratory syndrome virus resistant pigs. Genus plc was incorporated in 1994 and is based in Basingstoke, the United Kingdom.

Frequently asked questions

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site